Departments & Organizations
Yale Combined Program in the Biological and Biomedical Sciences (BBS): Molecular Medicine, Pharmacology, and Physiology: Cancer Biology and Therapeutics
Wendell Yarbrough, MD, MMHC is the Section Chief of Otolaryngology Department of Surgery, Director of the Head & Neck Disease Center at Smilow Cancer Hospital and Co-Director of the Molecular Virology Program in the Yale Cancer Center.
Dr. Yarbrough was a Morehead Scholar at the University of North Carolina at Chapel Hill where he also attended medical school and completed residency and fellowship. He joins Yale from Vanderbilt University where he was the Co-Leader of the Thoracic and Head and Neck Program at the Vanderbilt Ingram Cancer Center, as well as Professor of Otolaryngology and Cancer Biology.
Dr. Yarbrough has a longstanding clinical interest in head and neck cancers and research interests in head and neck cancer translational research as well as identification of tumor suppressors and their mechanism of action. Recently, Dr. Yarbrough's lab has focused on identification of molecular defects in subsets of head & neck and salivary cancers to serve as novel targets for therapy. Dr. Yarbrough's lab has expertise in cell and molecular biology and in modeling of tumors for pre-clinical testing. The ultimate goal of Dr. Yarbrough's lab work is to improve outcomes for patients with head & neck and salivary cancers through innovative and rational development of new therapies.
Learn more about Yale Otolaryngology's Section Chief.
Education & Training
|MMHC||Vanderbilt University (2010)|
|MD||University of North Carolina at Chapel Hill (1989)|
|Fellow||University of North Carolina at Chapel Hill School of Medicine|
|Resident||University of North Carolina at Chapel Hill School of Medicine|
|Internship||University of North Carolina at Chapel Hill School of Medicine|
|Board Certification||AB of Otolaryngology, Otolaryngology (1995)|